2 hours Insider Buying: Galectin Therapeutics Inc. (NASDAQ:GALT) Director Purchases 5,000 Shares of StockMarketBeat
Galectin Therapeutics Inc. (NASDAQ:GALT – Get Free Report) Director Kevin D. Freeman bought 5,000 shares of the firm’s stock in a transaction on Wednesday, October 16th. The stock was acquired at an average cost of $2.70 per share, with a total value o…
X